Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease-Reference-Cited by-同舟云学术

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease

Published:2020-08 Issue: Volume:131 Page:106764
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Juneja Amandeep,Zia Saqib,Abeysekara Aravinda,Shams Sara,Singh Kuldeep,Schor Jonathan,Deitch Jonathan

Funder

Northwell Health System

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference14 articles.

1. The epidemiology of peripheral arterial disease: importance of identifying the population at risk;Criqui;Vasc. Med. Lond. Engl.,1997

2. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

3. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction;Beckwith;Ann. Pharmacother.,1993

4. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients;Heart Outcomes Prevention Evaluation Study Investigators;N. Engl. J. Med.,2000

5. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation;Rakugi;Circulation,1994

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP;Clinical Hemorheology and Microcirculation;2024-06-25